Most important amongst these are the prospective studies revealing that the association between lower PON1 activity and ASCVD is not the consequence of the ASCVD event or its treatment or due to lower levels being associated with survival, but that it predates the clinical event [6,128,129,146,150,151]. This evidence concerns the gene PON1 and atherosclerosis.